Author

Ruomu Jiang

Institution: Helix (United States)

Observed institutions: Harvard University, Helix (United States)

OpenAlex ID: A5069303403

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

2021 · Jui-Hsia Weng, Peter David Koch, et al. · Nature Metabolism · 105

Bi‐allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer

2017 · Robert W Mutter, Nadeem Riaz, et al. · The Journal of Pathology · 68

Basal Activity of a PARP1-NuA4 Complex Varies Dramatically across Cancer Cell Lines

2014 · Kristin A. Krukenberg, Ruomu Jiang, et al. · Cell Reports · 20

Combining rare and common genetic variants improves population risk stratification for breast cancer

2024 · Alexandre Bolze, Daniel Kiser, et al. · Genetics in Medicine Open · 11

Comprehensive Allele Genotyping in Critical Pharmacogenes Reduces Residual Clinical Risk in Diverse Populations

2021 · Shishi Luo, Ruomu Jiang, et al. · Clinical Pharmacology & Therapeutics · 11

Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

2021 · Jui-Hsia Weng, Peter David Koch, et al. · Nature Metabolism · 1

Works count: 6

Citation count: 216

H-index: 5

I10-index: 5